Premium
[P3–041]: LMTM DECREASES α‐SYNUCLEIN PATHOLOGY AND REDUCES BEHAVIOURAL DEFECTS IN α‐SYNUCLEIN TRANSGENIC MICE
Author(s) -
Schwab Karima,
Frahm Silke,
Magbagbeolu Mandy,
Goatman Elizabeth A.,
Harrington Charles R.,
Wischik Claude M.,
Theuring Franz
Publication year - 2017
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2017.06.1854
Subject(s) - synucleinopathies , genetically modified mouse , transgene , disease , pathological , alpha synuclein , biology , neuroscience , parkinson's disease , pathology , medicine , gene , genetics